Effects of bacterial vaginosis-associated bacteria and sexual intercourse on vaginal colonization with the probiotic lactobacillus crispatus CTV-05

Sexually Transmitted Diseases

Volumn 38, Issue 11, 2011, Pages 1020-1027

  Ngugi, Benjamin M ^a,b   Hemmerling, Anke ^c   Bukusi, Elizabeth A ^a   Kikuvi, Gideon ^b,d   Gikunju, Joseph ^b   Shiboski, Stephen ^c   Fredricks, David N ^d,e   Cohen, Craig R ^c  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b JOMO KENYATTA UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Kenya)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL RNA; LACTIN V; METRONIDAZOLE; PLACEBO; PROBIOTIC AGENT; RNA 16S; UNCLASSIFIED DRUG;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ATOPOBIUM; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIAL VAGINITIS ASSOCIATED BACTERIUM; BACTERIUM CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GARDNERELLA VAGINALIS; GENE DOSAGE; HUMAN; HUMAN TISSUE; LACTOBACILLUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS INERS; LEPTOTRICHIA; MEGASPHAERA; PHASE 2 CLINICAL TRIAL; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL; SEXUAL INTERCOURSE; VAGINA FLORA; VAGINA SMEAR; VAGINITIS;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BACTERIA; COITUS; DNA, BACTERIAL; FEMALE; GARDNERELLA VAGINALIS; HUMANS; LACTOBACILLUS; METRONIDAZOLE; POLYMERASE CHAIN REACTION; PROBIOTICS; RNA, RIBOSOMAL, 16S; TREATMENT OUTCOME; VAGINA; VAGINOSIS, BACTERIAL; YOUNG ADULT;

EID: 80054123660     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3182267ac4     Document Type: Article

References (41)

1. Mitchell H. Vaginal discharge-causes, diagnosis, and treatment. BMJ 2004; 328:1306-1308.
2. Demba E, Morison L, van der Loeff MS, et al. Bacterial vaginosis, vaginal flora patterns and vaginal hygiene practices in patients presenting with vaginal discharge syndrome in The Gambia, West Africa. BMC Infect Dis 2005; 5:12.
3. Karaer A, Boylu M, Avsar AF. Vaginitis in Turkish women: Symptoms, epidemiologic-microbiologic association. Eur J Obstet Gynecol Reprod Biol 2005; 121:211-215. (Pubitemid 41074095)
4. Svare JA, Schmidt H, Hansen BB, et al. Bacterial vaginosis in a cohort of Danish pregnant women: Prevalence and relationship with preterm delivery, low birthweight and perinatal infections. BJOG 2006; 113:1419-1425. (Pubitemid 44736687)
5. Jacobsson B, Pernevi P, Chidekel L, et al. Bacterial vaginosis in early pregnancy may predispose for preterm birth and postpartum endometritis. Acta Obstet Gynecol Scand 2002; 81:1006-1010.
6. Schwebke JR. Gynecologic consequences of bacterial vaginosis. Obstet Gynecol North Am 2003; 30:685-694. (Pubitemid 38018632)
7. Bradshaw CS, Morton AN, Garland SM, et al. Higher-risk behavioral practices associated with bacterial vaginosis compared with vaginal candidiasis. Obstet Gynecol 2005; 106:105-114. (Pubitemid 40898441)
8. Ness RB, Kip KE, Soper DE, et al. Bacterial vaginosis (BV) and the risk of incident gonococcal or chlamydial genital infection in a predominantly black population. Sex Transm Dis 2005; 32:413-417. (Pubitemid 40875377)
9. Demirezen S, Korkmaz E, Beksac MS. Association between trichomoniasis and bacterial vaginosis: Examination of 600 cervicovaginal smears. Cent Eur J Public Health 2005; 13:96-98. (Pubitemid 40825400)
10. Taha TE, Hoover DR, Dallabetta GA, et al. Bacterial vaginosis and disturbances of vaginal flora: Association with increased acquisition of HIV. AIDS 1998; 12:1699-1706. (Pubitemid 28418342)
11. Bradshaw CS, Mortom AN, Garland SM, et al. Evaluation of a point-of-care test, BVBlue, and clinical and laboratory criteria for diagnosis of bacterial vaginosis. J Clin Microbiol 2005; 43:1304-1308. (Pubitemid 40364955)
12. Ferris MJ, Norori J, Zozaya-Hinchliffe M, et al. Cultivationindependent analysis of changes in bacterial vaginosis flora following metronidazole treatment. J Clin Microbiol 2007; 45: 1016-1018. (Pubitemid 46427726)
13. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005; 353:1899-1911. (Pubitemid 41565955)
14. Fredricks DN, Fiedler TL, Thomas KK, et al. Targeted polymerase-chain- reaction for the detection of vaginal bacteria associated with bacterial vaginosis. J Clin Microbiol 2007.
15. Carey JC, Klebanoff MA, Hauth JC, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Ne2rk of Maternal-Fetal Medicine Units. N Engl J Med 2000; 342:534-540. (Pubitemid 30117893)
16. Reid G, Charbonneau D, Erb J, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: Randomized placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 2003; 35:131-134. (Pubitemid 36298934)
17. Anukam KC, Osazuwa E, Osemene GI, et al. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect 2006; 8:2772-2776. (Pubitemid 44692555)
18. Bolton M, van der SA, Cohen CR. Probiotics: Potential to prevent HIV and sexually transmitted infections in women. Sex Transm Dis 2008; 35:214-225. (Pubitemid 351619515)
19. Martinez RC, Franceschini SA, Patta MC, et al. Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: A randomized, double-blind, placebo-controlled trial. Can J Microbiol 2009; 55:133-138.
20. Wilks M, Wiggins R, Whiley A, et al. Identification and H(2)O(2) production of vaginal lactobacilli from pregnant women at high risk of preterm birth and relation with outcome. J Clin Microbiol 2004; 42:713-717. (Pubitemid 38222651)
21. Kiss H, Kogler B, Petricevic L, et al. Vaginal Lactobacillus microbiota of healthy women in the late first trimester of pregnancy. BJOG 2007; 114:1402-1407. (Pubitemid 47609929)
22. Czaja CA, Stapleton AE, Yarova-Yarovaya Y, et al. Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infect Dis Obstet Gynecol 2007; 2007:35387.
23. Antonio MA, Meyn LA, Murray PJ, et al. Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous Lactobacilli. J Infect Dis 2009; 199: 1506-1513.
24. Hemmerling A, Harrison W, Schroeder A, et al. Phase 1 doseranging safety trial of Lactobacillus crispatus CTV-05 for the prevention of bacterial vaginosis. Sex Transm Dis 2009; 36:564-569.
25. Hemmerling A, Harrison W, Schroeder A, et al. Phase 2a study assessing colonization efficiency, safety, and acceptability of Lactobacillus crispatus CTV-05 in women with bacterial vaginosis. Sex Transm Dis 2010; 37:745-750.
26. Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74:14-22. (Pubitemid 13221599)
27. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29:297-301.
28. Antonio MAD, Hillier SL. DNA Fingerprinting of Lactobacillus crispatus strain CTV-05 by repetitive element sequence-based PCR analysis in a pilot study of vaginal colonization. J Clin Microbiol 2003; 41:1881-1887. (Pubitemid 36576507)
29. Fredricks DN, Relman DA. Paraffin removal from tissue sections for digestion and PCR analysis. Biotechniques 1999; 26:198-200. (Pubitemid 29072459)
30. Srinivasan S, Liu C, Mitchell CM, et al. Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS One 2010; 5:e10197.
31. Mastromarino P, Macchia S, Meggiorini L, et al. Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis. Clin Microbiol Infect 2009; 15:67-74.
32. Swidsinski A, Mendling W, Loening-Baucke V, et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol 2008; 198:97.e1-e6.
33. Yan DH, Lu Z, Su JR. Comparison of main Lactobacillus species between healthy women and women with bacterial vaginosis. Chin Med J (Engl) 2009; 122:2748-2751.
34. Song YL, Kato N, Matsumiya Y, et al. Identification of and hydrogen peroxide production by fecal and vaginal lactobacilli isolated from Japanese women and newborn infants. J Clin Microbiol 1999; 37:3062-3064. (Pubitemid 29391944)
35. Vasquez A, Jakobsson T, Ahrne S, et al. Vaginal Lactobacillus flora of healthy Swedish women. J Clin Microbiol 2002; 40: 2746-2749. (Pubitemid 35284935)
36. Antonio MA, Hawes SE, Hillier SL. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis 1999; 180:1950-1956.
37. Anukam KC, Osazuwa EO, Ahonkhai I, et al. Lactobacillus vaginal microbiota of women attending a reproductive health care service in Benin city, Nigeria. Sex Transm Dis 2006; 33:59-62. (Pubitemid 43042823)
38. Matu MN, Orinda GO, Njagi EN, et al. In vitro inhibitory activity of human vaginal lactobacilli against pathogenic bacteria associated with bacterial vaginosis in Kenyan women. Anaerobe 2010; 16:210-215.
39. Schwebke JR, Desmond RA, Oh MK. Predictors of bacterial vaginosis in adolescent women who douche. Sex Transm Dis 2004; 31:433-436. (Pubitemid 38812928)
40. Schellenberg J, Blake BT, Lane M, et al. Flow cytometric quantification of bacteria in vaginal swab samples self-collected by adolescents attending a gynecology clinic. J Microbiol Methods 2008; 73:216-226.
41. Ison CA, Hay PE. Validation of a simplified grading of Gram stained vaginal smears for use in genitourinary medicine clinics. Sex Transm Infect 2002; 78:413-415. (Pubitemid 36020813)